CCL26 and eosinophilic esophagitis: Since P-CAB was reported to be effective in PPI-refractory eosinophilic esophagitis [22], P-CAB might inhibit eotaxin-3, which inhibited the increase in the duodenal mucosal eosinophils in the current study.